Intravitreal Injection of Brolucizumab for Recalcitrant Macular Edema due to Central Retinal Vein Occlusion: A Small Case Series

This was a single center, prospective uncontrolled nonrandomized case series. Two eyes with recalcitrant ME secondary to CRVO, who have received a minimum of ten intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections, underwent IVI brolucizumab (BRZ). Patients underwent best cor...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakraborty, Debdulal, Mondal, Soumen, Boral, Subhendu, Das, Arnab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710446/
https://www.ncbi.nlm.nih.gov/pubmed/36466059
http://dx.doi.org/10.1159/000526710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710446/
https://www.ncbi.nlm.nih.gov/pubmed/36466059
http://dx.doi.org/10.1159/000526710

Ejemplares similares